Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-30 @ 3:59 AM
Study NCT ID:
NCT05210803
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-06-18
First Post:
2022-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-14
First Submit QC Date:
None
Study First Post Date:
2022-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-16
Last Update Post Date:
2025-06-18
Last Update Post Date Type:
ACTUAL